- Report
- October 2024
- 78 Pages
Global
From €3500EUR$3,970USD£3,081GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
Methylpiperazine is a pharmaceutical intermediate used in the production of active pharmaceutical ingredients (APIs). It is a cyclic amine compound with a wide range of applications in the pharmaceutical industry, including the synthesis of antifungal, antiviral, and anti-inflammatory drugs. It is also used in the production of contrast agents for medical imaging. Methylpiperazine is a versatile compound that can be used in a variety of reactions, including condensation, alkylation, and acylation.
Methylpiperazine is produced by a number of companies, including Merck KGaA, Sigma-Aldrich, and Alfa Aesar. It is also available from specialty chemical suppliers such as TCI Chemicals and ABCR GmbH. Additionally, there are a number of manufacturers in India, China, and other countries that produce methylpiperazine for the global market. Show Less Read more